A Case of Erythema Multiforme Major Developed after Sequential Use of Two Immune Checkpoint Inhibitors, Nivolumab and Ipilimumab, for Advanced Melanoma: Possible Implication of Synergistic and/or Complementary Immunomodulatory Effects
Immune checkpoint inhibitors, such as ipilimumab and nivolumab, reverse the imbalance of antitumor self-tolerance and enhance T-cell responses. Currently, ipilimumab and nivolumab have a reported therapeutic impact on unresectable or metastatic melanomas; however, they also induce immune-related adv...
Main Authors: | Akira Utsunomiya, Noritaka Oyama, Shiro Iino, Natsuki Baba, Takenao Chino, Natsuko Utsunomiya, Minoru Hasegawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2018-01-01
|
Series: | Case Reports in Dermatology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/485910 |
Similar Items
-
Pityriasis rosea with erythema multiforme - like lesions: An observational analysis
by: Vineet Relhan, et al.
Published: (2013-01-01) -
Oral Blistering - Report of Two Cases of Erythema Multiforme & Literature Review
by: Bharati Patil, et al.
Published: (2013-09-01) -
Erythema multiforme in leprosy
by: Alice Machado Miranda, et al.
Published: (2012-12-01) -
Erythema multiforme as the result of taking carbamazepine
by: Maharani Laillyza Apriasari, et al.
Published: (2010-06-01) -
Orf followed by erythema multiforme
by: M. Azizzadeh
Published: (2007-11-01)